<code id='FF0DDB9C57'></code><style id='FF0DDB9C57'></style>
    • <acronym id='FF0DDB9C57'></acronym>
      <center id='FF0DDB9C57'><center id='FF0DDB9C57'><tfoot id='FF0DDB9C57'></tfoot></center><abbr id='FF0DDB9C57'><dir id='FF0DDB9C57'><tfoot id='FF0DDB9C57'></tfoot><noframes id='FF0DDB9C57'>

    • <optgroup id='FF0DDB9C57'><strike id='FF0DDB9C57'><sup id='FF0DDB9C57'></sup></strike><code id='FF0DDB9C57'></code></optgroup>
        1. <b id='FF0DDB9C57'><label id='FF0DDB9C57'><select id='FF0DDB9C57'><dt id='FF0DDB9C57'><span id='FF0DDB9C57'></span></dt></select></label></b><u id='FF0DDB9C57'></u>
          <i id='FF0DDB9C57'><strike id='FF0DDB9C57'><tt id='FF0DDB9C57'><pre id='FF0DDB9C57'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:29731
          HHS 2020
          PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

          WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

          The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

          advertisement

          PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc
          Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

          INAFASSBENDER/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

          INAFASSBENDER/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog